Revvity, Inc. (NYSE:RVTY) Shares Bought by Royal London Asset Management Ltd.

Royal London Asset Management Ltd. lifted its stake in shares of Revvity, Inc. (NYSE:RVTY) by 15.5% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 50,437 shares of the company’s stock after purchasing an additional 6,770 shares during the period. Royal London Asset Management Ltd.’s holdings in Revvity were worth $5,629,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in RVTY. Empowered Funds LLC purchased a new position in Revvity in the third quarter worth approximately $227,000. Natixis Advisors LLC increased its position in shares of Revvity by 17.9% in the 3rd quarter. Natixis Advisors LLC now owns 12,499 shares of the company’s stock valued at $1,597,000 after purchasing an additional 1,901 shares during the last quarter. Quest Partners LLC acquired a new stake in shares of Revvity in the 3rd quarter valued at $126,000. Pathstone Holdings LLC lifted its position in shares of Revvity by 70.0% during the 3rd quarter. Pathstone Holdings LLC now owns 21,358 shares of the company’s stock worth $2,728,000 after purchasing an additional 8,791 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new position in Revvity in the third quarter valued at $393,000. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Revvity Trading Up 0.2 %

NYSE:RVTY opened at $107.18 on Monday. Revvity, Inc. has a 12-month low of $97.32 and a 12-month high of $129.50. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The stock’s 50 day simple moving average is $116.44 and its 200-day simple moving average is $117.54. The firm has a market cap of $12.88 billion, a P/E ratio of 48.50, a PEG ratio of 3.82 and a beta of 1.06.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period in the previous year, the company posted $1.25 EPS. Equities analysts anticipate that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be issued a dividend of $0.07 per share. The ex-dividend date is Thursday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.26%. Revvity’s dividend payout ratio is currently 12.67%.

Insider Activity at Revvity

In related news, insider Joel S. Goldberg sold 15,170 shares of the company’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares of the company’s stock, valued at $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the completion of the transaction, the insider now owns 19,652 shares of the company’s stock, valued at $2,295,550.12. The trade was a 21.84 % decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages have issued reports on RVTY. KeyCorp lifted their price target on Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Bank of America upgraded Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price for the company in a research note on Friday, December 13th. Barclays upped their price target on Revvity from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Raymond James reissued an “outperform” rating and set a $145.00 price objective (up previously from $140.00) on shares of Revvity in a report on Monday, February 3rd. Finally, Sanford C. Bernstein cut shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price for the company. in a report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Revvity has an average rating of “Moderate Buy” and an average price target of $136.25.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.